- Home
- WULF vs PTCT Comparison
WULF vs PTCT Comparison
Compare WULF & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WULF
- PTCT
- Stock Information
- Founded
- WULF 1952
- PTCT 1998
- Country
- WULF United States
- PTCT United States
- Employees
- WULF N/A
- PTCT N/A
- Industry
- WULF EDP Services
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- WULF Technology
- PTCT Health Care
- Exchange
- WULF Nasdaq
- PTCT Nasdaq
- Market Cap
- WULF 4.5B
- PTCT 4.8B
- IPO Year
- WULF 1995
- PTCT 2013
- Fundamental
- Price
- WULF $13.67
- PTCT $65.77
- Analyst Decision
- WULF Strong Buy
- PTCT Buy
- Analyst Count
- WULF 10
- PTCT 14
- Target Price
- WULF $12.35
- PTCT $67.00
- AVG Volume (30 Days)
- WULF 35.3M
- PTCT 1.2M
- Earning Date
- WULF 11-11-2025
- PTCT 11-06-2025
- Dividend Yield
- WULF N/A
- PTCT N/A
- EPS Growth
- WULF N/A
- PTCT N/A
- EPS
- WULF N/A
- PTCT 7.72
- Revenue
- WULF $144,085,000.00
- PTCT $1,764,929,000.00
- Revenue This Year
- WULF $47.72
- PTCT $120.26
- Revenue Next Year
- WULF $102.40
- PTCT N/A
- P/E Ratio
- WULF N/A
- PTCT $8.35
- Revenue Growth
- WULF 19.82
- PTCT 96.00
- 52 Week Low
- WULF $2.06
- PTCT $35.51
- 52 Week High
- WULF $13.73
- PTCT $67.40
- Technical
- Relative Strength Index (RSI)
- WULF 79.78
- PTCT 70.07
- Support Level
- WULF $11.25
- PTCT $62.32
- Resistance Level
- WULF $12.64
- PTCT $67.40
- Average True Range (ATR)
- WULF 0.84
- PTCT 2.09
- MACD
- WULF 0.03
- PTCT 0.15
- Stochastic Oscillator
- WULF 98.37
- PTCT 83.13
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.